Kura Oncology Inc. (KURA) reported Loss for its fourth quarter of -$80.999 million
The company's bottom line came in at -$80.999 million, or -$0.92 per share. This compares with -$19.217 million, or -$0.22 per share, last year.
The company's revenue for the period fell 67.8% to $17.336 million from $53.883 million last year.
Kura Oncology Inc. earnings at a glance (GAAP) :
-Earnings: -$80.999 Mln. vs. -$19.217 Mln. last year.-EPS: -$0.92 vs. -$0.22 last year.-Revenue: $17.336 Mln vs. $53.883 Mln last year.
For comments and feedback contact: editorial@rttnews.com
April 24, 2026 15:15 ET Economics news flow was relatively light this week even as the conflict in the Middle East continued, raising concerns for policymakers. In the U.S., spending data, initial jobless claims and pending home sales were the highlights. Business confidence in the biggest euro area economy was in focus in Europe. Inflation data from Japan gained attention in Asia.